US Patent Issued to DSM IP Assets on Feb. 17 for "Genetically engineered strains with reduced byproduct formation" (Danish Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,071, issued on Feb. 17, was assigned to DSM IP Assets B.V. (Heerlen, Denmark).

"Genetically engineered strains with reduced byproduct formation" was invented by Peter Becker (Horsholm, Denmark) and Manos Papadakis (Horsholm, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the production of oligosaccharides, especially Human milk Oligosaccharides (HMOs) using a genetically engineered cell which has decreased or total loss of function of phosphoglycerol transferase I and II and/or phosphoethanolamine transferase and/or glucans biosynthesis protein C to reduce oligosaccharide by-products and/or increase oligosac...